Kliniken der Stadt Koln gGmbH

Cologne 51109

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Primary Progressive, Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer — Completed
• A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis — Completed
• A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131] — Completed